Wuhan Guanggu Talent Fund
Wuhanovc-talent.com
Overview
Wuhan Guanggu Talent Fund is a Chinese venture capital firm established in 2015 to support the "3551 Optics Valley Talent Plan". It is a government-guided fund that focuses on investing in and incubating early-stage and startup enterprises founded by high-level talent within the Wuhan East Lake High-tech Development Zone (Optics Valley). The firm primarily targets emerging industries such as optoelectronic information, biomedicine, modern services, new energy, environmental protection, and high-end equipment manufacturing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hunan Shixin New Material Co., Ltd. | Mar 2026 | Series C Extension | Co-investor |
| 北京同创永益科技发展有限公司 | Nov 2020 | Series C | Co-investor |
| iRegene Therapeutics | Jan 2019 | Angel | Co-investor |
| Hzymes Biotechnology Co., Ltd. | Dec 2015 | Angel | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.